Skip to main content

    1st Precision Medicine in Immuno-Oncology Meeting

    Translation Research in Immuno-Oncology

    The success of recent, immune-based cancer therapies in generating durable responses in patients across multiple indications has been groundbreaking.
    Nevertheless, not all patients respond to such therapies.
    Development of predictive biomarkers to assess the likelihood of patient response prior to initiation of therapy is of increasing importance to patients, payers, and regulators.
    Issues and examples of work in this domain will be provided in this meting.

    Júlio Oliveira
    Lúcio Santos

    * Registration Deadline: June 29, 2017
    ** Pre-Meeting Course with limited space available


    Maria Augusta Guimarães

    We welcome you to the meeting 1st Precision Medicine in Immuno-Oncology that has been organized by IPO Immunology Department and IPO-Porto Research Center throught the group of Pathology and Experimental Therapy.
    The Immuno-Oncology is a way to gather acknowlegment among Doctors, Investigators and Laboratory Technicians
    All IPO Departments involved in this kind of therapies strongly participated on the organization of this event.
    We wish you a pleasant two days meeting at IPO-Porto.

    Scientific Program

    Gabriela Martins

    Graça Braz

    Júlio Oliveira

    Lúcio Lara Santos

    António Campos Júnior

    Armando Pinto

    Catarina Pinho

    Cristina Gaiteiro

    Gabriela Martins

    Graça Braz

    Inês Godinho

    Júlio Oliveira

    Lúcio Santos

    Maria Augusta Guimarães

    Susana Roncon





    Instituto Português Oncologia do Porto Francisco Gentil, EPE

    IPO – Porto

    4200-072 Porto

    Ligia Silva

    (+351) 914 592 380

    Jorge Pimentel

    (+351) 914 592 380